- Tytuł:
- Phase 1 Clinical Trial of PPMX‐T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics
- Autorzy:
- Źródło:
- Clinical Pharmacology in Drug Development; June 2023, Vol. 12 Issue: 6 p579-587, 9p
Periodyk